Figure S10 from MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Year: 2025
Type: other
Abstract: Supplemental Fig.S10. Treatment with deucravacitinib and/or mirdametinib did not decrease mouse body weight over time.
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416628784
